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ABSTRACT 
Background 
Crohn’s disease (CD) patients suffer from nutritional deficiencies when in active disease. We 
aim to examine calorific intake, macronutrient choice and disordered eating behaviour in 
patients with active CD.  
Methods  
CD patients with active disease were recruited with matched healthy volunteers (HV). Active 
disease was defined by faecal calprotectin >250ug/g, C-reactive protein >5mg/dl, or active 
disease seen on endoscopy or imaging. Symptoms were quantified by Harvey-Bradshaw 
Index (HBI). Calorific intake was assessed by 24-h dietary recall. Disordered eating was 
assessed using validated questionnaires [Binge Eating Scale (BES); Power of Food Scale 
(PFS); Control of Eating Questionnaire (CoEQ); Dutch Eating Behaviour Questionnaire 
(DEBQ); Three Factor Eating Questionnaire (TFEQ)].  
Results  
21 CD (14M:7F, Age:33.3±2.3, BMI:24.9±1.0) and 21 matched HV (14M:7F, Age:33.8±2.4, 
BMI:25.1±0.6) were recruited. Mean HBI was 5.1±0.8, faecal calprotectin 640±140µg/g and 
C-reactive protein 27±7.2mg/dl. There were no differences in calorific or macronutrient intake 
between groups. CD were characterised by higher BES (p=0.001), TFEQ-Disinhibition 
(p=0.006) and Hunger (p=0.014), DEBQ-Emotional (p=0.001) and External eating (p=0.022), 
PFS (p=0.007) and by lower CoEQ-Craving control (p=0.016) with greater craving for savoury 
compared to HV (p=0.005). There were no differences in dietary restraint measures. Hospital 
Anxiety and Depression score was higher (p=0.002) and CoEQ-Positive Mood (p=0.001) 
lower in CD. 
Conclusions   
Disordered eating behaviour traits were more prevalent in CD. Greater prevalence of binge 
eating may be attributed to lower mood and higher anxiety observed. Higher scores on 
measures of hedonic eating indicates that stronger psychological support with firm dietetic 
advice for healthy eating is warranted.  
Keywords 
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INTRODUCTION 
Patients with gastrointestinal disorders are at a greater risk of a disordered eating pattern 
compared to healthy volunteers with an increased prevalence of a wide range of abnormal 
eating patterns such as binge eating, meal skipping and food restriction 1,2. Disordered eating 
behaviour applies to most patients with gastrointestinal disease and may include food 
restriction, meal skipping and over-eating rather than the more severe eating disorders where 
patients are diagnosed according to specific narrow criteria. A disordered eating behaviour 
may be described with a two-path theoretical model1,2. The first pathway concerns individuals 
who experience high levels of anxiety about unfamiliar foods and/or overestimate the negative 
consequences associated with their condition. These individuals may restrict their intake to 
self-prepared and familiar foods limiting their diet variety. The second pathway concerns 
individuals who gain weight when following their prescribed dietary regimen and subsequently 
employ techniques to reduce this weight gain.  
In Inflammatory Bowel Disease (IBD), issues regarding food intake are felt to be either 
important or extremely important in 62.5% of patients, with virtually all Crohn’s disease (CD) 
patients having had problems with unintentional weight loss 3. Abnormal eating patterns have 
been described in IBD with qualitative studies unselectively describing eating behaviour 
irrespective of disease activity4,5. Approximately three-fourths of patients with IBD describe a 
decline in appetite when the disease is active4 with up to 37% of Crohn’s disease (CD) patients 
show abnormal eating patterns 6. Malnutrition is more prevalent in CD than ulcerative colitis 
with up to 75% of hospitalised patients being malnourished with 50% in negative nitrogen 
balance 7. To this effect, the IBD priority-setting partnership set up by the James Lind Alliance 
identified a research need to understand a role for diet in disease management8. The effect of 
disordered eating on the nutritional status in CD has never been investigated.   
Appetite and satiety involve complex interactions between homeostatic and hedonic factors. 
The enteroendocrine-gut brain axis is central to the homeostatic control of food intake, whilst 
other neural circuits integrate environmental and emotional cues to constitute the hedonic 
drive of appetite regulation 9. The cross-link between eating behaviour and active CD is poorly 
understood. Disordered eating might be associated with a change in the homeostatic and 
hedonic balance. The aim of this study is to examine free-living calorie and macronutrient 
intake in patients with active CD compared to healthy volunteers and to determine the 
prevalence and type of eating behaviour traits and disordered eating in CD patients with active 
disease.   
 
 
  
 
METHODOLOGY  
Basic protocol and patient recruitment  
This was an open label, qualitative questionnaire-based study with a matched-pair design. 
The study was conducted between July 2015 and December 2016 at the National Institute of 
Health Research (NIHR) Nottingham Digestive Diseases Biomedical Research Centre (NDD 
BRC) at the Queens Medical Centre Campus, Nottingham, UK. Participants were recruited 
from The Inflammatory Bowel Disease Clinic, via the study flyer and social media. CD patients 
(aged 16-75yrs) with active disease were recruited as well as age, BMI and gender-matched 
healthy volunteers. Healthy volunteers (HV) were recruited form an existing participant 
database in the Nottingham BRC and from the local healthy populations of Nottingham 
University Hospitals and the University of Nottingham. This study was advertised through 
study fliers and social media.  
Disease activity was defined through objective markers of inflammation: faecal calprotectin of 
>250µg/g or CRP of >5g/dl or through recent ileocolonoscopy, CT or MR enterography 
showing active inflammatory and uncomplicated disease (not of a stricturing or penetrating 
behaviour). CD clinical activity was measured with a Harvey Bradshaw Index10(HBI) score 
recorded at inclusion. Potential participants with a BMI of <18 or >30kg/m2, recent 
corticosteroid use (in the last 3 months), pregnancy or breast-feeding and patients with 
significant co-morbidities were excluded from the study. Stable doses of immunosuppressive 
agents or anti-TNF agents were permitted.  
All CD patients and healthy volunteers gave their informed consent prior to recruitment. All 
participants were included in this study for a maximum of one week. Participants completed a 
single, spontaneously administered 24hr dietary recall either face-to-face at the NDD BRC or 
by telephone, the Hospital Anxiety and Depression scale (HADS) and five psychometric eating 
behaviour questionnaires within the study period.  
Outcomes 
The primary outcome of this study was to compare total 24 hr calorie intake as measured by 
a single face-to-face or telephone-administered 24-hour dietary recall 11 between CD with 
active disease and age-, BMI- and gender-matched HV. Calories consumed were calculated 
for the recall based on manufacturers’ labels and the nutrition analysis tool Nutritics (Nutritics 
v4.312 Academic Edition, Ireland). Dietary recall did not include caloric intake from weekends 
or holidays but only days Monday to Thursday. The secondary endpoint for this study was to 
measure eating behaviour traits through psychometric scales: Three Factor Eating 
  
Questionnaire (TFEQ) 12; the Binge Eating Scale 13; the Power of Food Scale 14; the Dutch 
Eating Behaviour Questionnaire 15; and the Control of Eating Questionnaire 16,17.  
24-h dietary recall  
The Automated Multiple-Pass Method (AMPM) was utilised to perform the single 
spontaneously administered 24hr dietary recall. This five-step questionnaire can accurately 
assess dietary consumption and may be administered face-to-face or by telephone 11,18. RW, 
AN and GT conducted all interviews. A copy of the dietary assessment textbook Carbs and 
Cals was provided to each participant to facilitate the dietary recall 19. This book contains over 
1700 food and drink photographs and was primarily used to assist in identifying the appropriate 
food type and portion size consumed. Diet logs were analysed using Nutritics dietary analysis 
software (Nutritics v4.312 Academic Edition, Ireland). 
Eating Behaviour traits 
Eating behaviour traits were measured through five validated self-report questionnaires; the 
Power of Food Scale (PFS); the Binge Eating Scale (BES); the Control of Eating Questionnaire 
(COEQ); Three Factor Eating Questionnaire (TFEQ) and the Dutch Eating Behaviour 
Questionnaire (DEBQ) 12-16.  
 
The Power of Food Scale (PFS)  
The PFS is a 15-item questionnaire reflecting the psychological influence of the food 
environment. It measures appetite for, rather than consumption of palatable foods and may 
be a useful measure of the hedonic impact of food environments replete with highly palatable 
foods 20. Items are grouped into three domains according to food proximity; food available but 
not physically present, food present but not tasted and food tasted but not consumed.  
The Binge Eating Scale (BES)  
The BES is a 16-item questionnaire that assesses the severity of binge eating tendencies. 
Eight questions describe the behavioural manifestations of binge eating behaviour and eight 
describe the feelings and cognitions associated with binge eating. Scores are summed to 
produce a total score ranging from 0 to 46. Cut off points have previously been reported 
denoting mild (≤17), moderate (18–26), and severe (≥27) binge eating behaviour 13,21,22. 
The Control of Eating Questionnaire (CoEQ)  
The CoEQ is a 21-item questionnaire designed to assess the severity and type of food 
cravings experienced over the previous seven days 16. The CoEQ has four subscales; Craving 
Control, Craving for Savoury, Craving for Sweet and Positive Mood. Items on the CoEQ are 
  
assessed by 100-mm visual analogue scales (VAS) with items relating to each subscale being 
averaged to create a final score. 
Three Factor Eating Questionnaire (TFEQ) 
The TFEQ contains 51-items and measures three dimensions of human eating behaviour; 
Cognitive Restraint of Eating, Disinhibition and Hunger 12. Restraint refers to concern over 
weight control and strategies which are adopted to achieve this. Disinhibition reflects a 
tendency towards over-eating and eating opportunistically in an obesogenic environment. 
Hunger is concerned with the extent to which hunger feelings are perceived and the extent to 
which such feelings evoke food intake 23. Each item scores either 0 or 1 point. The minimum 
score for factors I, II and III is therefore 0, with the possible maximum scores being 21, 16 
and14 respectively.   
The Dutch Eating Behaviour Questionnaire (DEBQ)  
The 33-item DEBQ assesses different eating styles that may contribute to weight gain; 
emotional eating, external eating, and restraint. ‘Emotional eating’ occurs in response to 
emotional arousal states such as fear anger or anxiety, ‘external eating’ in response to external 
food cues such as sight and smell of food and ‘restraint eating’ is overeating after a period of 
slimming when the cognitive resolve to diet is abandoned15. 
Statistical Analysis  
The sample size was based on published data where the 24hr self-reported calorie intake in 
CD was 1978.7±169.7Kcal and that in HV was 1854.4 ±129.5Kcal. Assuming α of 0.05, power 
of 80% and using 2-sided test, 30 participants in each group were needed to show a significant 
difference in the primary outcome.  
Data were analysed using SPSS version 20 for Windows. The parametric or non-parametric 
nature of the data was determined by a normality test. Data is presented as mean ± standard 
error of the mean (SEM). Continuous data was compared using paired t-test while categorical 
data was compared with Chi-Squared test. Total 24hr Kcal intake, macronutrient intake 
together with outcome data from the individual questionnaires administered to all participants 
were compared between the groups. An exploratory sub-analysis was undertaken comparing 
differences between gender. P values <0.05 were deemed significant.  
Ethical approval  
This study received research ethics committee approval from National Research Ethics 
Service (NRES) Committee East Midlands (REC reference 15/EM/0142 as of the 27th April 
2015). The protocol was registered with clinical trials.gov (NTC02379117). 
  
RESULTS  
Demographic data 
Thirty CD patients (18M:12F, Age:32.3±2.19, BMI:24.9±0.8) and 31 matched HV (19M:12F, 
Age:32.8±2.0, BMI:24.7±0.5) were recruited to this matched pairs cross-sectional study (see 
Table 1). There were no significant differences in gender ratio, mean age and mean BMI 
between the CD and HV. CD patients had clinically active disease with a mean HBI score of 
7.2±0.7 and objective evidence of active disease with an elevated C-reactive protein 
(83.8±47.1mg/L), or faecal calprotectin (1009.2±192.9µg/g) or as assessed by colonoscopy 
or MR enterography or both (see supplementary table). These objective investigations have 
been undertaken as part of the patients’ standard of care within a mean of 52.9±14.1 days of 
recruitment. None of the patients had any change in management prior to recruitment and 
data collection.  
Table 1: Summary demographic data of participants 
Group Gender (n) Age  BMI 
CD M (18) 31.1±2.7  24.1±1.1  
 F (12) 34.1±3.8  26.1±1.2  
    
HC M (19) 32.6±2.3 24.7±0.6 
 F (12)  33±3.9 24.8±1.0 
 
24-hour calorie intake 
The total self-reported 24-hour calorie and macronutrient intake for the CD cohort and HV are 
shown in Table 2. There were no significant differences observed in total energy intake 
between cohorts. Protein intake was significantly lower in the CD cohort (CD, 92.6g±7.8; HV, 
70.3g±6.1; p=0.003). There was no significant difference in the consumption of all other 
macronutrients.   
In a sub-analysis of this data setaimed at investigating difference by gender, the 24hr calorie 
intake of male CD patients was not significantly different to male HV. In female participants, 
24-hour calorie intake was significantly reduced in the CD cohort compared with HV (CD, 
1519.3±136.5; HV, 2039.4Kcal±133.8; p=0.01).  In female participants consumption of 
carbohydrate (CD, 187.9g±19.9 HV, 270.1g±22.3, p=0.01), sugars (CD, 78.9±8.5; HV, 
107.5±9.3; p=0.03) and fibre (CD, 15.9g±2.6; HV, 25.9g±3.8; p=0.04) was significantly less 
than in HV.  
  
Table 2. 24-hour self-reported calorie and macronutrient intake in CD and HV. Data is 
presented as mean and Standard error of the mean 
 CD  
(total) 
CD  
(male) 
CD 
(female) 
HV  
(total) 
HV  
(male) 
HV  
(female) 
Total (Kcal) 1900.9± 
138.6 
2187± 
193.7 
1519.3± 
136.5 
2054.3 ± 
110.7 
 
2065± 
167 
2039.4± 
133.8 
Carbohydrate (g) 248.4±  
20.7 
 
 
293.7± 
28.5 
187.9± 
19.9 
255.9± 
17.3 
 
245.9± 
25.3 
270.1± 
22.3 
Sugar (g) 97.8± 
8.1 
 
112± 
11.6 
78.9± 
8.5 
101.7± 
7.4 
 
97.6± 
10.9 
107.5± 
9.3 
Protein (g) 70.3± 
6.1 
 
74.0± 
8.5 
65.4± 
8.8 
92.6± 
7.8 
 
101.6± 
12.2 
79.9± 
6.8 
 
Fat (g) 69.7± 
6.2 
 
79.4± 
8.2 
56.9± 
8.3 
72.3± 
5.3 
 
73.8± 
8.1 
70.2± 
6.2 
Saturated Fat (g) 23.1± 
2.1 
 
26.2± 
2.5 
18.9± 
3.3 
 
23.1± 
2.2 
 
23.6± 
3.4 
 
22.5± 
2.5 
Fibre (g)  18.9 ±  
2.1 
 
21.2± 
3.0 
15.9± 
2.6 
23.4± 
2.3 
21.7± 
2.8 
25.9± 
3.8 
Alcohol (g) 3.5± 
1.8 
 
5.0± 
2.9 
1.5± 
1.5 
 
4.6± 
1.9 
 
5.5± 
2.8 
 
3.4± 
2.2 
 
Hospital Anxiety and Depression Scale 
  
CD patients had significantly higher scores on the Hospital Anxiety and Depression scale 
compared to HV (CD, 13.4±1.6; HV, 7.4±1.5; p=0.01) (see Table 3). This was evident for both 
anxiety (CD, 8.6±0.9; HV, 4.2±0.7; p=0.001) and depression (CD, 6±0.9; HV, 1.8±0.3; p=0.00) 
subscales.  
In addition, CD patients scored significantly lower on the CoEQ Positive Mood subscale (CD, 
50.8±3.3; HV, 64.8±2.5; p=0.001). 
Eating Behaviour traits 
Table 3 shows the outcomes from the psychometric eating behaviour questionnaires for CD 
and HV. CD patients scored higher on BES compared to HV (CD, 10.9±1.9; HV, 5.2±1.0; 
p=0.01) and a greater proportion of CD patients (29%) scored above the clinical cut-off criteria 
for moderate levels of binge eating (>17 BES) compared to HV (3.3%) [χ2 (1) = 7.0, p=0.008].  
CD patients reported lower levels of CoEQ Craving Control (CD, 56.16±3.5; HV, 66.4±2.9; 
p=0.027) and greater craving for sweet (CD, 48.9±4.4; HV, 37.3±3.5; p=0.043) and savoury 
(CD, 48.9±3.5; HV, 38.3±2.7; p=0.021) foods compared to HV. CD patients had higher scores 
on the PFS food present (CD, 11.7±0.7; HV, 9.0±0.6; p=0.005) subscale. No significant 
difference was seen however for overall PFS score or food available or tasted subscales.  
In addition, CD patients scored higher on the DEBQ Emotional Eating (CD, 36.4±3.7; HV, 
20.0±1.7; p=<0.001) and External Eating (CD, 30.8±1.9; HV, 25.2±1.2; p=0.022) subscales 
compared to HV. However, there was no difference in restraint assessed by either or DEBQ 
(CD, 23.7±2.7; HV, 21.6±1.9; p=0.528) the TFEQ (CD, 6.4±0.9; HV, 8.4±0.9; p=NS) between 
CD and HV.  
 
 
 
 
 
 
 
 
 
  
Table 3. Eating behaviour traits in CD participants and age-, BMI- and gender-matched HV.  
 CD HV Sig. (2-tailed) 
HADS 13.4±1.6 
 
7.4±1.5 
 
0.01 
HADS: Anxiety 8.6±0.9 4.2±0.7 0.001 
 
HADS: Depression 6.0±0.9 1.8±0.3 0.001 
 
BES 10.9±1.9 
 
5.2±1.0 
 
0.01 
PFS 35.6±2.4 
 
31.0±1.9 
 
0.27 
PFS: Available 12.1±1.2 
 
10.5±0.9 
 
0.28 
PFS: Present 11.7±0.7 9.0±0.6 0.005 
PFS: tasted 11.7±0.8 
 
11.7±0.8 
 
0.954 
CoEQ: Control 56.2±3.5 66.4±2.9 
 
0.027 
CoEQ: Sweet 48.9±4.4 37.3±3.5 
 
0.043 
CoEQ: Savoury 48.9±3.5 38.2±2.7 
 
0.021 
CoEQ: Mood 50.7±3.3 64.8±2.5 
 
0.001 
TFEQ: R 5.9±0.9 8.4±0.9 
 
0.114 
TFEQ: D 6.1±0.8 4.5±0.6 
 
0.135 
TFEQ: H 5.5±0.8 4.0±0.5 0.142 
DEBQ: R 23.7±2.7 21.6±1.9 0.528 
DEBQ: Em 36.4±3.7 20.0±1.7 
 
<0.001 
DEBQ: Ex 30.8±1.9 25.2±1.2 0.022 
 
When analysed by gender, male CD showed significant difference in HADS (CD 13.5±2.1; 
HV, 4.3±1; p=0.001), BES (CD, 7.3±1.6; HV, 3.4±0.8; p=0.04) CoEQ: Control (CD 58.9±4.4; 
HV, 70.5±3.3; p=0.04) CoEQ: Sweet (CD, 51.5±6.2; HV, 32.9±4.1; p=0.01), TFEQ: Restraint 
(CD, 4.1±0.8; HV, 8.3±1.1; p=0.00) and DEBQ: Emotional (CD, 31.4±4.2; HV, 18.9±1.9; 
p=0.01) when compared with male HV.  
  
Female CD showed significant difference in HADS (CD, 15.9±2.9; HV, 8.6±1.6; p=0.04), PFS: 
Present (CD, 12.8±1; HV, 9.6±1; p=0.04), CoEQ: Mood (CD, 44.1±5.2; HV, 64.1±4.1; p=0.006) 
and DEBQ: Emotional (CD, 43.8±6; HV, 22±3.4; p=0.01) when compared with female HV.  
 
DISCUSSION  
A poor nutritional status has always been associated with CD but a detailed analysis of eating 
behaviour in this cohort compared to matched HV has never been undertaken. The primary 
aim of this study was to compare the total self-reported 24 hr calorie intake in CD with active 
disease and HV. The main secondary aim was to examine whether CD patients with active 
disease had a greater prevalence of disordered eating patterns compared to HV.  We found 
no substantial difference in the 24-hour self-reported calorie intake between CD patients with 
objective evidence of intestinal inflammation and HV. Analysing the data further by gender 
reveals that a significant decrease in calorie intake is observed in female rather than male CD 
patients with this reduction in food intake consisting mainly of a reduction in carbohydrates in 
females and protein in males.  This finding is novel and contrasts with observations made 
inprevious studies that have showed no difference in energy intake in CD patients with both 
active and inactive disease2425. These differences in food intake may be explained by the two-
path theoretical model; with CD patients experiencing high levels of anxiety to food intake, 
thus restricting food variety to minimise symptom aversion.  
An increased prevalence of disordered eating behaviour traits was observed in CD with a 
greater prevalence of binge eating, food craving, lower mood and higher anxiety states 
observed in this group. Patients with gastrointestinal disorders are reported to suffer from 
disordered eating behaviour with more than a third of CD patients thought to be affected 6. In 
the present study, it was demonstrated that CD patients scored significantly higher on 
measures of binge eating and hedonic responsiveness compared to HV. Binge eating traits 
were more prevalent as revealed by a significantly higher BES together with significantly 
stronger cravings with less ability of self-control. The CoEQ showed that CD patients had less 
control of their cravings, with significantly greater cravings for both sweet and savoury foods.  
Significantly higher scores on the hedonic eating traits (i.e. BES, PFS, DEBQ-External) in CD 
may be associated with increased food monitoring behaviour that occurs in patients with 
dietary-controlled conditions, something that should be examined in future research. These 
findings are consistent with previous research that have demonstrated a higher level of 
disordered eating patterns in individuals with gastrointestinal disorders 1,2. In a questionnaire-
based study in 400 consecutive IBD patients in the UK4, approximately half of the patients felt 
that diet was the initiating factor in IBD and subsequent relapses. The majority of patients’ 
  
symptoms were triggered by food with two-thirds of the patients depriving themselves of their 
favourite food to achieve symptom control. A case-control study of 104 patients with an 
established diagnosis of IBD26 concluded that avoidance of meat, nuts, fruit and vegetables 
are more common among patients with IBD than healthy controls. This corresponds with the 
findings of this study where the consumption of protein was significantly reduced overall and 
carbohydrate, sugar and fibre intake were reduced in females.  
The current study also demonstrated that CD patients had lower levels of positive mood as 
measured by the CoEQ and higher scores on the HAD scale. Greater levels of psychological 
distress have been linked to increased binge eating prevalence and in the current study we 
found that scores on the BES were negatively associated with positive mood. Similarly, we 
found a higher prevalence of emotional eating in the DEBQ. These findings have important 
implications for the role of mood and psychological distress in the aetiology of gastrointestinal 
disorders and their association with abnormal eating patterns 27.  For example, it is possible 
that psychological distress may serve as both a cause and a consequence of disordered 
eating behaviours 1. Arigo et al suggested that fear and anxiety surrounding gastrointestinal 
symptoms may lead to disordered eating practices of a restrictive nature, as observed in this 
study 28. This increased anxiety may link directly to the personal attitudes and beliefs that 
patients hold about food. In a French survey of 244 IBD patients, nearly half of the study 
patients reported that the disease had changed the pleasure of eating5 with only a quarter of 
the patients eating a normal diet when they relapse. Such a behaviour influenced patients’ 
social life in 25% of the cases. This might have a negative effect on mood and depressive 
symptoms.  
Disease activity has been quantified with objective markers of disease activity and intestinal 
inflammation present in all our recruited cohort. Clinical scores were quantified through HBI.  
Gastrointestinal symptom severity may also play an important role in the development of 
disordered eating patterns, with greater symptom severity correlating positively with the risk 
of disordered eating30.  
When analysed by gender, female CD patients consumed significantly less calories than 
female HV with reduced consumption of carbohydrate, sugar and fibre. This was not observed 
in male participants. Male CD participants displayed greater hedonic responsiveness with 
higher BES, lower CoEQ Control and TFEQ:Restraint compared with male HV. In females CD 
participants, significantly higher PFS: present and DEBQ: Emotional with lower CoEQ: 
moodwhen compared with female HV might imply female CD patients may be predisposed to 
emotional eating. These results seem may suggest that female patients have similar level self-
control over dietary consumption as HV. Consequently, females with CD may be less likely to 
  
binge eat during active disease, being more likely to display inadequate calorie consumption 
as displayed by this study. Male CD participants display greater hedonic responsiveness, with 
higher prevalence of binge eating with the consequence of normalising calorie consumption 
to that of HV male participants. It is important to highlight that this study was not powered to 
analyse the difference in eating behaviour by gender so such conclusions are hypothesis-
generating.  
We believe that for the first time, this study highlights in detail the important behavioural 
differences that may be observed in patients with active CD. This study has some limitations 
that need to be considered. This was an 18-month long prospective study aiming to compare 
calorific intake and the eating behaviour of CD patients with active disease to matched healthy 
volunteers. The sample size despite relatively small was appropriately powered based on the 
group’s previous pilot data. Daily activity levels are an important confounder that were not 
measured. Physical inactivity has already been shown in CD31,32, and has been significantly 
correlated to disease activity but is still prevalent in remission33. Due to the small sample size, 
we did not investigate the effect of disease burden surrogates: disease duration, concomitant 
medication and surgical history in CD patients on eating behaviour.  Nevertheless, the CD 
cohort recruited is representative of a CD cohort with moderate disease burden, making our 
findings generalizable to world-wide healthcare systems.  
The use of the AMPM as a single administered 24-hour recall is limited, and accuracy may 
have been improved if this was performed on three consecutive days rather than one day. 
However, this method has been used successfully in previous research 18. The 24-hour recall 
technique is also memory dependent and participants’ potential bias in reporting “good/bad” 
foods may affect the accuracy of the outcome. In this study, the 24-hour recall data was 
collected by three interviewers, which may have introduced inter-rater variability in the data 
collected. Additionally, during dietary recall, if a manufacturer’s nutritional label was not 
available, portion size was obtained using the Carbs and Cals textbook as a visual aid, which 
may have affected the estimation of portion size. When assessing eating behaviours, the use 
of multiple behavioural questionnaires may have introduced an element of participant fatigue 
that may have decreased the specificity of the responses given. The order of these 
questionnaires was administered randomly to all participants throughout the study to mitigate 
this risk. Future studies should use additional methods such as weighed food records, and 
laboratory test meals to measure food intake in patients with active CD and to confirm the 
caloric intake findings of the present study.  
Biochemical, endoscopic and radiological objective measures of disease activity have been 
acquired as part of routine standard of care rather than as a specific screening process for 
  
this study. For this reason, there was a variable lag between the dates of these assessments 
and recruitment to this study. None of these patients changed their maintenance therapy after 
these investigations and prior to recruitment within this study.  
In conclusion, this study has highlighted the significantly higher prevalence of emotional eating 
and food monitoring behaviour in CD. Clinically these results imply that stronger psychological 
and firm dietetic education may be of benefit in CD. Nearly half of the IBD patients have never 
received dietetic advice and two-thirds feel they need more support4. Questioning patients on 
their attitudes and beliefs through counselling or psychotherapy may alter these behaviours. 
Firm dietetic advice for healthy eating should also be advocated. Additionally, combating 
underlying anxiety and depression in these patients may improve disordered eating traits. The 
UK IBD standards in 2013 highlighted the need for formal psychological support in IBD teams 
with only 24% of adult IBD services have defined access to a psychologist with an interest in 
IBD34.  
This study has provided new evidence regarding the complexity of disordered eating 
behaviour traits in active CD. A more objective understanding is needed regarding the fine 
balance between homeostatic and hedonic control of food intake in intestinal inflammation.  
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 SEX AGE BMI MONTREAL HBI CRP  FCP  MRI COLONOSCOPY 
P01 F 48 24.9 A1L3B2 - - - - Post op recurrence Rutgeerts i3 
P02 M 22 21.8 A2L1B3 - - - - Post op recurrence Rutgeerts i3 
P03 M 51 21.4 A2L1B2 - - 316 multifocal active small bowel 
disease 
 
P04 F 23 26.7 A2L3B1 5 - - - Diffuse punched out ulcerations in 
terminal ileum 
P05 M 30 25.5 A2L3B3 - - - - Colonoscopy  - Rutgeerts i2 
P06 M 25 26.2 A2L3B1 - - 1763 - - 
P07 M 23 20 A2L3B3 - - - 30cm of TI disease with an 
enter-enteric fistula 
- 
P08 F 37 24.3 A2L1B2 9 - - Terminal ileitis - 
P10 F 23 23.1 A2L1B1 5 - - - Diffuse punched out ulcerations in 
terminal ileum 
P11 M 35 33.7 A2L3B1p - 52 - - rectosigmoid inflammation with a 
perianal fistula 
P13 F 29 36 A2L1B1 7 - - 6cm terminal ileum 
inflammatory disease 
- 
P14 M 32 29.6 A2L3B3p - - - pancolonic inflammatory 
disease with distal sparing. 
Has a desc colon stricture. 
Distal 3cm TI inflamed 
- 
P15 M 57 18.6 A3L1B3 10 - - mixed inflammatory and 
stricturing disease in the ileum 
- 
P16 F 33 24.9 A2L2B1 - - 449 - severe colonic disease with puynched 
out ulcers 
P17 F 40 27.6 A3L1B3 - - - 30cm of terminal ileal 
inflammatory disease 
- 
P19 M 49 25.7 A3L3B1 - - - 15cm of terminal ileal 
inflammatory disease 
- 
P20 
M 33 22.5 A2L3L4B2 - - 
1800 
extensive jejunal disease - 
P23 
M 20 19.37 A2L3B3 7 - - - Post op recurrence Rutgeerts i2 
P24 
M 28 18.6 A2L1B1 - - - - 
Diffuse punched out ulcerations in 
terminal ileum 
P25 
M 23 23.4 A2L3B1p - 
- - Diffuse terminal ileal 
inflammatory disease 
- 
P26 
M 38 30.6 A2L3B2 - 
- 785 - 
- 
P27 
F 35   - 
- 1226  
 
P28 
F 22   - 
38   
Ruterts i2 
  
P29 
M 20   - 
- 1027  
 
P30 
F 68   - 
224 - extensive transverse colonic 
disease with fistulisation 
 
P31 
M 31   - 
- 607 chronic disease 
 
P32 
F 28   - 
- 319  
 
P33 
F 24   - 
- -  
mild patchy colitis with loss of vascular 
pattern, erythema in R colon. 
P34 
M 25   - 
- 1800 Thickening of the terminal 
ilium 
 
P35 
M 18   8 
- -  
 
 
     
   
 
SUPPLEMENTARY TABLE: CD PARTICIPANT DEMOGRAPHIC STUDY INCLUSION CRITERIA 
 
  
 
